How to Access Combined Genomic Sequencing and Microbiome Testing as a Cancer Patient

Written by Sean Kimbrough, Founder & Executive Director, Courage Against Cancer
Sourced from peer-reviewed and IRB-registered clinical research · Last updated June 18, 2026

Table of Contents Introduction Semantic Glossary Step 1: Understanding What Testing Is Available to You Step 2: Finding the Right Providers and Labs Step 3: Navigating Costs, Coverage, and Integrative Support Frequently Asked Questions Conclusion Medical Disclaimer Introduction At Courage Against Cancer (CAc) , we believe that informed patients make empowered decisions. Accessing combined genomic sequencing and microbiome testing is a practical step that aligns with emerging, evidence-based approaches to personalized cancer care. These two testing modalities — when pursued together — provide a more complete biological picture of your cancer environment. This guide walks you through the realistic, actionable steps to access these tests, understand your options, and work collaboratively with your care team to support better treatment and recovery outcomes. Semantic Glossary Genomic Sequencing (Tumor Profiling) A laboratory process that analyzes the DNA of cancer cells to identify specific mutations, gene expressions, or biomarkers driving tumor growth. Results can guide targeted therapy decisions. Microbiome Testing An analysis of the microbial communities — primarily in the gut — that influence immune function, inflammation, and how the body responds to cancer treatments including chemotherapy and immunotherapy. Integrative Oncology A patient-centered discipline that combines conventional cancer treatments with evidence-informed complementary approaches — including nutrition, supplementation, and functional testing — to support overall wellbeing and treatment response. Liquid Biopsy A minimally invasive blood test that can detect circulating tumor DNA, offering a genomic snapshot without requiring surgical tissue sampling. Step 1: Understanding What Testing Is Available to You Before requesting testing, it helps to understand what currently exists and what it can reveal. Comprehensive genomic profiling (CGP) panels — such as those offered by FoundationOne, Tempus, or Guardant — analyze hundreds of cancer-related genes simultaneously Whole exome sequencing (WES) and whole genome sequencing (WGS) provide broader genomic data and are increasingly accessible through academic cancer centers Gut microbiome tests from companies like Viome, Genova Diagnostics, or Psomagen assess microbial diversity, bacterial imbalances, and gut immune markers Combination testing programs are emerging at integrative oncology clinics, where both genomic and microbiome data are reviewed together as part of a functional health assessment Evidence-based data increasingly supports the idea that gut microbial diversity correlates with immunotherapy response — a fact that endorses CAc’s mission to explore the full biological terrain of cancer care Understanding what genomic sequencing is and why it matters for cancer patients empowers you to ask specific, informed questions during your next oncology appointment. Step 2: Finding the Right Providers and Labs Knowing where to go is as important as knowing what to order. Academic medical centers and NCI-designated cancer centers frequently offer or facilitate access to comprehensive genomic sequencing as part of standard care Integrative oncologists and functional medicine physicians are often the most accessible providers for microbiome testing in a cancer context — they understand how to interpret results alongside conventional treatment Direct-to-patient lab services allow some microbiome tests to be ordered without a physician referral, though professional interpretation is strongly recommended Ask your oncologist specifically about tumor molecular profiling — if your cancer type qualifies, this may already be standard practice at your institution Look for multidisciplinary tumor boards at larger cancer centers, where genomic data is routinely reviewed by specialists CAc recommends connecting with providers who are familiar with emerging, non-conventional supportive approaches — including medicinal mushrooms, targeted supplementation, and other avenues that may complement your genomic sequencing results and how they determine your specific cancer type and treatment plan 🔗 Related Reading: How Can Combining Genomic Sequencing and Microbiome Testing Transform Your Cancer Treatment Recovery? (Parent Pillar) Step 3: Navigating Costs, Coverage, and Integrative Support Cost remains one of the most significant barriers for many patients — but options exist. Insurance coverage for genomic sequencing has expanded significantly; Medicare and many private insurers now cover CGP for certain cancer types — verify eligibility with your insurance provider and ask for a prior authorization letter Patient assistance programs through genomic testing companies (e.g., Foundation Medicine’s patient support program) can reduce or eliminate out-of-pocket costs Microbiome testing is typically not covered by insurance and ranges from $150–$400 — however, it represents a relatively low-cost addition given its potential clinical value Clinical trials frequently include genomic profiling at no cost to participants — search clinicaltrials.gov for trials relevant to your cancer type CAc’s educational resources can help you identify integrative practitioners and evidence-informed support programs that incorporate these tools into a broader recovery strategy Fact: Evidence-based data suggests that microbiome optimization — through diet, probiotics, and targeted interventions — may support better treatment tolerance, a cornerstone of CAc’s integrative philosophy — and the powerful connection between your gut microbiome and cancer treatment outcomes helps explain why this optimization matters so much during active treatment 🔗 Related Reading: What Does the Research Say About the Gut Microbiome and Immunotherapy Response? (Cluster Article) Frequently Asked Questions Q: Can I request genomic sequencing on my own, or does my oncologist need to order it? Most comprehensive genomic profiling requires a physician order and a tissue or blood sample. However, some liquid biopsy tests are available through direct-to-consumer channels. Always involve your oncologist to ensure results are properly interpreted and integrated into your care plan. Q: Is microbiome testing scientifically validated for cancer patients? Research in this area is actively growing. Evidence-based data shows associations between gut microbiome composition and outcomes in immunotherapy patients. While standardized clinical protocols are still developing, the science strongly supports its relevance as an educational and monitoring tool. Q: How do I bring up combined testing with a skeptical oncologist? Come prepared with published research. Frame the conversation around supporting treatment response and reducing side effects rather than replacing any conventional therapy. Asking “Is there a clinical trial or integrative oncology referral available?” is often a productive starting point. If you’re unsure how to start that conversation, listening to expert perspectives on genomic testing in cancer care can help you prepare for a productive and informed discussion. Conclusion Accessing combined genomic sequencing and microbiome testing is increasingly within reach for cancer patients willing to advocate for themselves. By understanding available tests, identifying the right providers, and navigating financial resources, you can take a meaningful step toward more personalized, informed care. Courage Against Cancer (CAc) is here to support that journey — every step of the way. 🔗 Return to Parent Pillar: How Can Combining Genomic Sequencing and Microbiome Testing Transform Your Cancer Treatment Recovery? CAC Wellness Playbook Curious what your own microbiome and genomic results could reveal? CAC Wellness Playbook combines both types of testing with a personal coach to help you build a recovery-focused plan around your own data. Medical Disclaimer The content provided by Courage Against Cancer (CAc) is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any decisions about your cancer care, testing, or treatment plan. CAc does not endorse any specific laboratory, product, or provider mentioned in this article.

---

About This Content: This article was written and curated by CAC’s founder, drawing on peer-reviewed and IRB-registered clinical research. CAC is in the process of establishing a formal Medical Review Board and will update our content review process as reviewers join. This content is for educational purposes only and is not medical advice — always consult your healthcare team before making treatment decisions.